This profile was last updated on .
Is this you? Claim your profile.
+ Get 10 Free Contacts a Month
Please agree to the terms and conditions
Chief Executive Officer and Investor Conference
Managing Director, Co-Head and Founder of the Telecommunications and Industry Group
GR Advisors, LLC
Chairman and Chief Executive Officer
Advanced Cell Technology , Inc.
Recently, ACTC commented on U.S. Appeals' Court's dismissal ruling in case challenging federal funding of embryonic stem cell research.
ACTC CEO Rabin said that the court ruling should be of considerable benefit to the company and its embryonic stem cell-based clinical programs.
Rabin said that the ruling effectively removes major speed bumps for the National Institutes of Health in terms of approving the several stem cell lines that ACTC has submitted for their consideration for funding.
Rabin also said that the ruling removes a great deal of ambiguity that has hampered legislative attempts to provide an efficient mechanism for federal funding of hESC research.
Interviews - The Niche
To See Again (Advanced Cell Technology, Inc) - Stock Pick 101
Berman & Rabin P.A
COHEN RABIN STINE SCHUMANN LLP
University of the Incarnate Word
Keller Williams Realty Inc.